Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02326259 · ClinicalTrials.gov registry record
Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia
A clinical trial, sponsored by Temple University.
- Completed
- Registry status
- 20
- Enrollment target
NCT02326259: Completed study, sponsored by Temple University.
NCT02326259 is a clinical trial that has completed, run by Temple University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02326259 has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The investigators are doing this research for two reasons. The first is to see how the retina (back of your eye) changes when your blood sugar is treated with medication for the first time. This will help us better understand the progression of a condition known as Diabetic Retinopathy. The second reason is to provide diabetic blood samples, which will possibly help identify biomarkers for diabetic retinopathy. Biomarkers are things that indicate the presence of a specific condition, and indicate a higher likelihood of developing that condition.
Interventions
- OTHER Initiation of treatment of diabetes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-03 |
| Est. Completion | 2022-03 |
What the finished NCT02326259 record still lists
NCT02326259 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Initiation of treatment of diabetes is the first listed.
NCT02326259 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02326259 about?
NCT02326259 is a clinical study titled "Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia". The investigators are doing this research for two reasons. The first is to see how the retina (back of your eye) changes when your blood sugar is treated with medication for the first time. This will help us better understand the progression of a condition known as Diabetic Retinopathy. The second r...
What is the current status of trial NCT02326259?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-03. Estimated completion is 2022-03.
What interventions are being tested in trial NCT02326259?
The interventions under investigation include: Initiation of treatment of diabetes (OTHER).
Who is sponsoring clinical trial NCT02326259?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia